Cyban
Company

Last deal

$6.2M

Amount

Series A

Stage

11.12.2023

Date

3

all rounds

$11.5M

Total amount

General

About Company
Cyban revolutionizes brain injury detection and treatment worldwide.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2019

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Cyban develops a next-generation non-invasive monitor that continuously provides accurate brain oxygen measurements from the site of trauma to hospital discharge. Their simple-to-use brain pulse oximeter delivers clinically relevant information, enabling early detection and intervention for better patient outcomes. The device interconnects with central patient monitoring systems, improving diagnosis accuracy and treatment times. Cyban's patented technology empowers confident clinical care at every stage of the patient journey.